Q3 2025 Earnings Call Transcript November 14, 2025 MiNK Therapeutics, Inc. beats earnings expectations. Reported EPS is ...

Q3 2025 Earnings Call Transcript November 13, 2025 zSpace, Inc. misses on earnings expectations. Reported EPS is $-0.26 EPS, expectations were $-0.2. Operator: Hello, and thank you for participating ...

DLocal posts strong TPV growth in Q3 despite pricing concerns. I estimate DLO stock to have 42% upside to $19.2. See more ...

Major stock indexes finished mixed Friday, with the Dow Jones Industrial Average declining for a second straight session but ...

Virgin Galactic said the Flight Test Program is on track to commence in the third quarter of 2026, with the first commercial ...

IQSTEL Inc (NASDAQ: IQST) stock fell on Friday after announcing Q3 financial results. Quarterly revenue of $102.8M, up 90% YoY, beat estimates.

Atea Pharmaceuticals, Inc. (NASDAQ: AVIR) Q3 2025 Earnings Call Transcript November 12, 2025 Atea Pharmaceuticals, Inc.

Q3 2025 Earnings Call November 13, 2025 5:00 PM ESTCompany ParticipantsPaul Kellenberger - CEO & ChairpersonErick DeOliveira - ...

Highlights Net revenue of $1.7 billion, an increase of 11.8% compared to Q3 2024Adjusted EBITDA1 increase of 17.8% to $323.4 million and adjusted ...

Gross profit was $9.3 million, or 88.5% of net revenue, compared to $14.2 million or 77.0% of net revenue in Q3 2024. The increase reflects a product mix shift towards our products that do not carry a ...

CARDIAMP CMI Cohort Results -- In the open-label rolling cohort (n=5), patients saw an average 80-second increase in exercise ...

Fate Therapeutics Inc. FATE) on Thursday reported a loss of $32.3 million in its third quarter. The San Diego-based company said it had a loss of 27 cents per share.